4//SEC Filing
TETRALOGIC PHARMACEUTICALS CORP 4
Accession 0001192482-13-000245
CIK 0001361248operating
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 12:54 PM ET
Size
7.2 KB
Accession
0001192482-13-000245
Insider Transaction Report
Form 4
Meyers Peter A.
CFO & Treasurer
Transactions
- Award
Stock Option
2013-12-17$7.00/sh+164,394$1,150,758→ 487,888 totalExercise: $7.00Exp: 2023-12-17→ Common Stock (164,394 underlying) - Purchase
Common Stock
2013-12-17$7.00/sh+142,857$999,999→ 142,857 total
Footnotes (1)
- [F1]Twenty-five percent (25%) of the options or 41,098 options vested at the closing of the Company's initial public offering on 12/17/13; the balance of the options become exercisable at the rate of 3,424 options per month until all of the options are vested with 3,456 vested in the final month. Vesting ceases if the employee is no longer an active full-time employee of the Company on the vesting date. If there is a change of control as defined in the Company's 2013 Equity Plan, the entire unvested portion of the shares shall become immediately vested.
Documents
Issuer
TETRALOGIC PHARMACEUTICALS CORP
CIK 0001361248
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001361248
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 12:54 PM ET
- Size
- 7.2 KB